AAAAAA
Results:
1-17
|
Results: 17
Authors:
ADAMS C
DUGGAN L
WAHLBECK K
WHITE P
Citation: C. Adams et al., THE COCHRANE SCHIZOPHRENIA GROUP, Schizophrenia research, 33(3), 1998, pp. 185-186
Authors:
WAHLBECK K
RIMON R
Citation: K. Wahlbeck et R. Rimon, CSF ACE CORRELATES WITH DURATION OF ILLNESS IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 103-103
Authors:
WAHLBECK K
CHEINE M
ESSALI A
REZK E
Citation: K. Wahlbeck et al., IS CLOZAPINE MORE EFFECTIVE THAN CONVENTIONAL NEUROLEPTICS IN SCHIZOPHRENIA - A SYSTEMATIC COCHRANE REVIEW, Schizophrenia research, 29(1-2), 1998, pp. 144-144
Authors:
WAHLBECK K
CHEINE M
ESSALI A
Citation: K. Wahlbeck et al., CLOZAPINE IN SCHIZOPHRENIA - A SYSTEMATIC COCHRANE REVIEW OF 27 TRIALS, Nordic journal of psychiatry, 52, 1998, pp. 24-24
Authors:
WAHLBECK K
Citation: K. Wahlbeck, THE BRAIN RENIN-ANGIOTENSIN SYSTEM IN SCHIZOPHRENIA AND PAIN DISORDER- WAHLBECK,K, Nordic journal of psychiatry, 52(1), 1998, pp. 78-79
Authors:
WAHLBECK K
AHOKAS A
MIETTINEN K
NIKKILA H
RIMON R
Citation: K. Wahlbeck et al., HIGHER CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME LEVELS IN NEUROLEPTIC-TREATED THAN IN DRUG-FREE PATIENTS WITH SCHIZOPHRENIA, Schizophrenia bulletin, 24(3), 1998, pp. 391-397
Authors:
CHEINE MV
WAHLBECK K
TUISKU K
JOFFE G
Citation: Mv. Cheine et al., RISPERIDONE VERSUS CLOZAPINE IN THE TREATMENT OF NEUROLEPTIC-REFRACTORY INTOLERANT SCHIZOPHRENIA-PATIENTS - A SINGLE-BLIND RANDOMIZED TRIAL- PRELIMINARY-REPORT OF AN ON-GOING STUDY/, Nordic journal of psychiatry, 51(2), 1997, pp. 99-99
Authors:
WAHLBECK K
CHEINE M
ESSALI A
Citation: K. Wahlbeck et al., EFFICIENCY OF CLOZAPINE IN SCHIZOPHRENIA - A SYSTEMATIC COCHRANE REVIEW AND METAANALYSIS, Nordic journal of psychiatry, 51(2), 1997, pp. 100-100
Authors:
WAHLBECK K
AHOKAS A
NIKKILA H
MIETTINEN K
RIMON R
Citation: K. Wahlbeck et al., A LONGITUDINAL-STUDY OF CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME IN NEUROLEPTIC-TREATED SCHIZOPHRENIA, Progress in neuro-psychopharmacology & biological psychiatry, 21(4), 1997, pp. 591-599
Authors:
SUNDBLOM DM
KALSO E
TIGERSTEDT I
WAHLBECK K
PANULA P
FYHRQUIST F
Citation: Dm. Sundblom et al., NEUROPEPTIDE FF-LIKE IMMUNOREACTIVITY IN HUMAN CEREBROSPINAL-FLUID OFCHRONIC PAIN PATIENTS AND HEALTHY CONTROLS, Peptides, 18(7), 1997, pp. 923-927
Authors:
JOFFE G
VENALAINEN E
TUPALA J
HILTUNEN O
WAHLBECK K
GADEKE R
RIMON R
Citation: G. Joffe et al., THE EFFECT OF CLOZAPINE ON THE COURSE OF ILLNESS IN CHRONIC-SCHIZOPHRENIA - FOCUS ON TREATMENT OUTCOME IN OPEN-CARE PATIENTS, Schizophrenia research, 18(2-3), 1996, pp. 5-5
Authors:
WAHLBECK K
AHOKAS A
NIKKILA H
RIMON R
Citation: K. Wahlbeck et al., HIGHER CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME LEVELS IN NEUROLEPTIC-TREATED THAN IN DRUG-FREE SCHIZOPHRENICS, Schizophrenia research, 18(2-3), 1996, pp. 14-14
Authors:
WAHLBECK K
AHOKAS A
NIKKILA H
RIMON R
Citation: K. Wahlbeck et al., HIGHER CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME LEVELS IN NEUROLEPTIC-TREATED THAN IN DRUG-FREE SCHIZOPHRENICS, Nordic journal of psychiatry, 50(2), 1996, pp. 98-98
Authors:
JOFFE G
VENALAINEN E
TUPALA J
HILTUNEN O
WAHLBECK K
GADEKE R
RIMON R
Citation: G. Joffe et al., THE EFFECT OF CLOZAPINE ON THE COURSE OF ILLNESS IN CHRONIC-SCHIZOPHRENIA - FOCUS ON TREATMENT OUTCOME IN OUT-PATIENTS, International clinical psychopharmacology, 11(4), 1996, pp. 265-272
Authors:
WAHLBECK K
SUNDBLOM M
KALSO E
TIGERSTEDT I
RIMON R
Citation: K. Wahlbeck et al., ELEVATED PLASMA VASOPRESSIN AND NORMAL CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC PAIN DISORDER, Biological psychiatry, 40(10), 1996, pp. 994-999
Authors:
KATILA H
HURME M
WAHLBECK K
APPELBERG B
RIMON R
Citation: H. Katila et al., PLASMA AND CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA INTERLEUKIN-6 IN HOSPITALIZED SCHIZOPHRENIC-PATIENTS, Neuropsychobiology, 30(1), 1994, pp. 20-23
Authors:
KATILA H
CANTELL C
APPELBERG B
WAHLBECK K
NAUKKARINEN H
RIMON R
Citation: H. Katila et al., INTERFERON-A AS ADJUVANT TREATMENT IN CHRONIC-SCHIZOPHRENIA, Neuropsychobiology, 28(4), 1993, pp. 192-196
Risultati:
1-17
|